Markus Herrmann
Chair of Institute, Clinical Institute of Medical and Chemical Laboratory Diagnostics, Medical University of Graz
Professor Markus Herrmann graduated in medicine at the University of Würzburg (GER). In 2007, he completed his training as clinical pathologist at the University of Saarland (GER). In the same year, Markus received a postdoc-grant and moved to Sydney. There he worked at the ANZAC-Research- Institute, the Royal-Prince-Alfred Hospital and at Laverty Pathology. In 2011 he received RCPA fellowship and became an associate professor at the University of Sydney. Between 2012 and 2017, Markus directed the Central Laboratory at Bolzano Hospital (ITA). In 2017, he became full professor and director of the Clinical Institute of Medical and Chemical Laboratory Diagnostics at the Medical University of Graz (AUT). His research group is primarily focused on metabolic factors that promote degenerative bone disease, and in particular vitamin D. He is an active member of the scientific committee on bone metabolism of the International Federation of Clinical Chemistry (IFCC). Other areas of expertise include vitamin B6, B9, B12 and K, as well as bile acids. Under Professor Herrmann’s leadership, the institute evolved into an internationally renowned center of clinical mass spectrometry.
